4.5 Article

Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region

Eleonora Del Prete et al.

Summary: The study found a higher prevalence of COVID-19 in the PD population compared to in Tuscany and Italy. PD patients did not experience a subjective worsening of symptoms during the lockdown period, and they were also favorable to telemedicine, although there was reduced availability to perform it.

JOURNAL OF NEUROLOGY (2021)

Review Medicine, General & Internal

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

Samantha K. Brooks et al.

LANCET (2020)

Article Health Care Sciences & Services

Telemedicine in Parkinson's Disease: How to Ensure Patient Needs and Continuity of Care at the Time of COVID-19 Pandemic

Giuseppina Miele et al.

TELEMEDICINE AND E-HEALTH (2020)

Letter Clinical Neurology

COVID-19 in Parkinson's disease: Report on prevalence and outcome

Carlo Alberto Artusi et al.

PARKINSONISM & RELATED DISORDERS (2020)

Review Geriatrics & Gerontology

The Neuropsychiatry of Parkinson Disease: A Perfect Storm

Daniel Weintraub et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2019)

Article Clinical Neurology

Advanced stages of PD: interventional therapies and related patient-centered care

Rejko Krueger et al.

JOURNAL OF NEURAL TRANSMISSION (2016)

Article Clinical Neurology

Treatment of Parkinson's disease in the advanced stage

C. Ossig et al.

JOURNAL OF NEURAL TRANSMISSION (2013)